Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy.

Area of Science:

• * Pharmaceutical Nanotechnology
• * Cancer Therapeutics
• * Natural Product Chemistry

Background:

• * Curcumin, derived from turmeric, exhibits potent anticancer properties.
• * Poor bioavailability and solubility limit curcumin's clinical use.
• * Nanotechnology offers a strategy to enhance curcumin's efficacy.

Purpose of the Study:

• * To review advancements in curcumin-based nanoparticles (CNPs) for cancer therapy.
• * To explore various nanoparticle formulations and their impact on curcumin's pharmacokinetics.
• * To detail the anticancer mechanisms and clinical efficacy of CNPs.

Main Methods:

• * Comprehensive literature review of CNP design, synthesis, and application.
• * Analysis of studies on polymeric, lipid-based, and inorganic nanoparticle formulations.
• * Examination of preclinical and clinical data on CNPs in various cancers.

Main Results:

• * CNPs significantly improve curcumin's bioavailability and therapeutic index.
• * CNPs demonstrate anticancer effects via apoptosis induction, proliferation inhibition, and pathway modulation.
• * Preclinical and clinical studies show CNP efficacy in breast, colorectal, and pancreatic cancers.

Conclusions:

• * CNPs represent a promising approach to enhance curcumin's anticancer potential.
• * Further research is needed to optimize CNP design for targeted delivery and clinical translation.
• * CNPs hold potential for advancing novel cancer treatment strategies.